A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants
Since summer 2020, SARS-CoV-2 strains at the origin of the COVID-19 pandemic have suddenly been replaced by new SARS-CoV-2 variants, some of which are highly transmissible and spread at a high rate. These variants include the Marseille-4 lineage (Nextclade 20A.EU2) in Europe, the 20I/501Y.V1 variant...
Main Authors: | Philippe Colson, Christian A. Devaux, Jean-Christophe Lagier, Philippe Gautret, Didier Raoult |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/15/3276 |
Similar Items
-
Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4’ variant
by: Pierre-Edouard Fournier, et al.
Published: (2021-05-01) -
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
by: David R. Martinez, et al.
Published: (2021-07-01) -
Treatment of SARS-CoV-2 relapse with remdesivir and neutralizing antibodies cocktail in a patient with X-linked agammaglobulinaemia
by: Emanuele Palomba, et al.
Published: (2021-09-01) -
SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
by: Thi Loi Dao, et al.
Published: (2021-06-01) -
Remdesivir, compuesto con potencial terapéutico contra SARS-CoV-2
by: Anthony Paul Bautista-Pariona, et al.
Published: (2021-02-01)